Rani Therapeutics Holdings (RANI) Operating Leases (2022 - 2026)
Rani Therapeutics Holdings' Operating Leases came in at $2.22 million for Q2 2026, down 30.6% from $3.2 million a year earlier and down 10.5% from the prior quarter.
Powered by 
Analysis
Rani Therapeutics Holdings (RANI) Operating Leases (2022 - 2026) Analysis & Trends
At the end of FY2025, Rani Therapeutics Holdings' Operating Leases was $2.73 million, down 24.9% from FY2024.
- Operating Leases carries a three-year compound annual growth rate of 259.1% (FY2022 to FY2025).
- Going back by year, Operating Leases was $3.64 million in FY2024 and $59,000 in FY2022.
- The Q2 2026 figure represents the lowest quarterly Operating Leases since Q3 2023.
- Year-over-year, Operating Leases has declined for six consecutive quarters, with an average decline of 27.4% over the last six quarters.
- The fastest year-over-year change in Operating Leases over five years came in Q1 2024 (growth of 849.8%), and the weakest in Q3 2023 (a decline of 46.2%).
- Business Quant data shows RANI's Operating Leases at $2.48 million (Q1 2026), $2.73 million (Q4 2025) and $2.97 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Rani Therapeutics Holdings | 110.43 Mn | -381,884.91 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.22 Mn |
| Mar 31, 2026 | 2.48 Mn |
| Dec 31, 2025 | 2.73 Mn |
| Sep 30, 2025 | 2.97 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Dec 31, 2024 | 3.64 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Jun 30, 2024 | 4.39 Mn |
| Mar 31, 2024 | 4.75 Mn |
| Sep 30, 2023 | 171,000.00 |
| Jun 30, 2023 | 338,000.00 |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 59,000.00 |
| Sep 30, 2022 | 318,000.00 |
| Jun 30, 2022 | 341,000.00 |
| Mar 31, 2022 | 509,000.00 |
API Access
Rani Therapeutics Holdings Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=RANI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "RANI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=RANI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();